Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Mar 23;10:5512. doi: 10.1038/s41598-020-62323-1

Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

Martin McPhillie 1,#, Ying Zhou 2,#, Kamal El Bissati 2, Jitender Dubey 3, Hernan Lorenzi 4, Michael Capper 5, Amanda K Lukens 6,7, Mark Hickman 8, Stephen Muench 1, Shiv Kumar Verma 3, Christopher R Weber 2, Kelsey Wheeler 2, James Gordon 1, Justin Sanders 9, Hong Moulton 9, Kai Wang 10, Taek-Kyun Kim 10, Yuqing He 10, Tatiana Santos 11, Stuart Woods 12, Patty Lee 8, David Donkin 8, Eric Kim 8, Laura Fraczek 2, Joseph Lykins 2, Farida Esaa 2, Fatima Alibana-Clouser 2, Sarah Dovgin 2, Louis Weiss 11, Gael Brasseur 13, Dyann Wirth 6,7, Michael Kent 9, Leroy Hood 10, Brigitte Meunieur 14, Craig W Roberts 12, S Samar Hasnain 5, Svetlana V Antonyuk 5,, Colin Fishwick 1,, Rima McLeod 2,
PMCID: PMC7089975  PMID: 32251362

Correction to: Scientific Reports 10.1038/srep29179, published online 14 July 2016

This Author Correction corrects the following errors in the Article. The authors neglected to cite a relevant study related to the isolation of the EGS strain of Toxoplasma gondii from amniotic fluid from a congenitally infected Brazilian fetus. As a result, in the Introduction,

“To address these challenges, we characterized the EGS parasite (Fig. 1), isolated in 1994 from amniotic fluid of a congenitally infected Brazilian fetus25, that form cyst-like structures in vitro.”

should read:

“To address these challenges, we characterized the EGS parasite (Fig. 1; ATCC® PRA-396), isolated in 1994 from amniotic fluid of a congenitally infected Brazilian fetus1 that form cyst-like structures in vitro25.”

In the Results section, under subheading ‘Characterization of EGS strain develops novel in vitro models to test compounds’,

“This AP2 represses bradyzoite to tachyzoite conversion, among other differences (Table 1; Fig. 1c; Supplement A: Box and Figure S2, Supplement B: Excel Table S1).”

should read:

“This AP2 represses tachyzoite to bradyzoite conversion2, among other differences (Table 1; Fig. 1c; Supplement A: Box and Figure S2, Supplement B: Excel Table S1).”

In Figure 6d, the incorrect image for transfected EGS was used. The correct Figure 6d appears below as Figure 1.

Figure 1.

Figure 1

.

Finally, in the Discussion section,

“This Apetela 2 plant like transcription factor gene is known to drive tachyzoite switch by repressing bradyzoite genes.”

should read:

“This Apetela 2, plant-like transcription factor gene, AP2IV-4, represses bradyzoite genes during the tachyzoite cell cycle, thereby preventing commitment to the bradyzoite developmental pathway2.”

Footnotes

These authors contributed equally: Martin McPhillie and Ying Zhou.

Contributor Information

Svetlana V. Antonyuk, Email: antonyuk@liverpool.ac.uk

Colin Fishwick, Email: c.w.g.fishwick@leeds.ac.uk.

Rima McLeod, Email: rmcleod@uchicago.edu.

References

  • 1.Castro F. C. Correlacáo do diagnóstico pósnatal da toxoplasmose congenita com a reacao em cadeia da polimerase no líquido amniótico, inoculaqáo em camundongo e achados anatomopatológicos da placenta. Thesis, Belo Horizonte, Brazil89 (1999).
  • 2.Radke, J. B. Transcriptional control of Toxoplasma development. PhD dissertation, University of South Florida, http://scholarcommons.usf.edu/etd/5108 (2014).

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES